NZ580948A - Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof - Google Patents

Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof

Info

Publication number
NZ580948A
NZ580948A NZ580948A NZ58094808A NZ580948A NZ 580948 A NZ580948 A NZ 580948A NZ 580948 A NZ580948 A NZ 580948A NZ 58094808 A NZ58094808 A NZ 58094808A NZ 580948 A NZ580948 A NZ 580948A
Authority
NZ
New Zealand
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Application number
NZ580948A
Other languages
English (en)
Inventor
Michael Christie
Joseph J Petraitis
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NZ580948A publication Critical patent/NZ580948A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
NZ580948A 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof NZ580948A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (1)

Publication Number Publication Date
NZ580948A true NZ580948A (en) 2011-04-29

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ580948A NZ580948A (en) 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof

Country Status (14)

Country Link
EP (1) EP2152669A1 (enrdf_load_stackoverflow)
JP (1) JP5698887B2 (enrdf_load_stackoverflow)
KR (1) KR20100017565A (enrdf_load_stackoverflow)
CN (1) CN101679237A (enrdf_load_stackoverflow)
AU (1) AU2008248168B2 (enrdf_load_stackoverflow)
BR (1) BRPI0810330A2 (enrdf_load_stackoverflow)
CA (1) CA2686033A1 (enrdf_load_stackoverflow)
EA (1) EA019031B1 (enrdf_load_stackoverflow)
IL (1) IL201627A (enrdf_load_stackoverflow)
MX (1) MX2009011787A (enrdf_load_stackoverflow)
NZ (1) NZ580948A (enrdf_load_stackoverflow)
UA (1) UA99913C2 (enrdf_load_stackoverflow)
WO (1) WO2008137087A1 (enrdf_load_stackoverflow)
ZA (1) ZA200907643B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ574873A (en) 2006-07-25 2012-03-30 Cephalon Inc Pyridazinone derivatives as h3 inhibitors
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) * 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
US10259794B2 (en) * 2014-12-23 2019-04-16 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
EP3847157B1 (en) * 2018-09-07 2022-05-18 Sanofi Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate and a salt thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
WO2005085307A1 (ja) 2004-03-08 2005-09-15 Japan Science And Technology Agency 高分子担持金属クラスター組成物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
DE602005004404T2 (de) 2004-06-02 2009-01-15 F. Hoffmann-La Roche Ag Als histamin-3-rezeptorliganden einsetzbare naphthalene-derivate
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
JP2008524252A (ja) 2004-12-17 2008-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Cns障害の処置のためのテトラヒドロイソキノリン化合物
JP2008526895A (ja) 2005-01-21 2008-07-24 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なイミダゾールおよびベンゾイミダゾール誘導体
US7790720B2 (en) 2005-03-31 2010-09-07 Ucb Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
US7943605B2 (en) 2005-10-27 2011-05-17 Ucb Pharma S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
WO2007094962A2 (en) 2006-02-09 2007-08-23 Athersys, Inc. Pyrazoles for the treatment of obesity and other cns disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
WO2007105053A2 (en) 2006-03-13 2007-09-20 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
NZ574873A (en) * 2006-07-25 2012-03-30 Cephalon Inc Pyridazinone derivatives as h3 inhibitors

Also Published As

Publication number Publication date
EA200971019A1 (ru) 2010-04-30
CN101679237A (zh) 2010-03-24
IL201627A0 (en) 2010-05-31
KR20100017565A (ko) 2010-02-16
CA2686033A1 (en) 2008-11-13
AU2008248168A1 (en) 2008-11-13
MX2009011787A (es) 2009-11-13
BRPI0810330A2 (pt) 2014-10-14
EP2152669A1 (en) 2010-02-17
IL201627A (en) 2014-06-30
WO2008137087A1 (en) 2008-11-13
AU2008248168B2 (en) 2013-03-21
JP5698887B2 (ja) 2015-04-08
JP2010526142A (ja) 2010-07-29
UA99913C2 (ru) 2012-10-25
EA019031B1 (ru) 2013-12-30
ZA200907643B (en) 2014-03-26

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP6117430B2 (ja) 選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物
JP6392888B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての新規化合物およびこれを含む薬剤学的組成物
CN103354808B (zh) 抗病毒化合物
NL1032713C2 (nl) Histamine-3-receptorantagonisten.
AU2021308344B2 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
ZA200603861B (en) Use of tricyclic compounds as glycine transport inhibitors
TW200403237A (en) New pyrrolidinium derivatives
WO2000017163A1 (fr) Derives de cyanophenyle
NZ580948A (en) Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof
KR20230158007A (ko) 항바이러스 화합물
WO2010059393A1 (en) Serotonin receptor modulators
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
NZ511791A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
AU2007329808A1 (en) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulators
CA2500115A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
AU2006316609A1 (en) Modulators of the H3 receptor useful for the treatment of disorders related thereto
JP2010526142A5 (enrdf_load_stackoverflow)
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2005252178B2 (en) Histamine H3 receptor agents, preparation and therapeutic uses
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
Vohra et al. Tertiary 3-aminopropenones and 3-aminopropenoates: Their preparation, with and without Lewis acids, from secondary amines and 1, 3-diketo compounds
RU2817736C1 (ru) Новые соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их
JP7672386B2 (ja) オレキシン受容体調節薬としての(2h-1,2,3-トリアゾール-2-イル)フェニル化合物の改善された合成方法

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed